Maryanna E. Lanning

534 total citations
15 papers, 472 citations indexed

About

Maryanna E. Lanning is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Maryanna E. Lanning has authored 15 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Maryanna E. Lanning's work include Chemical Synthesis and Analysis (6 papers), Cell death mechanisms and regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Maryanna E. Lanning is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Cell death mechanisms and regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Maryanna E. Lanning collaborates with scholars based in United States, United Kingdom and Norway. Maryanna E. Lanning's co-authors include Steven Fletcher, Jeremy L. Yap, Lijia Chen, Paul T. Wilder, Kwan‐Young Jung, Alexander D. MacKerell, Mithun Raje, E. E. Whiting, Jeffrey Strovel and Makoto Yoshioka and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Maryanna E. Lanning

15 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryanna E. Lanning United States 13 388 199 77 67 37 15 472
Johannes Belmar United States 7 315 0.8× 230 1.2× 104 1.4× 34 0.5× 56 1.5× 7 493
Smitha Kizhake United States 14 310 0.8× 132 0.7× 162 2.1× 36 0.5× 36 1.0× 20 490
Ying‐Chao Duan China 13 659 1.7× 479 2.4× 108 1.4× 66 1.0× 43 1.2× 27 1.1k
Yanong D. Wang United States 13 260 0.7× 516 2.6× 107 1.4× 118 1.8× 46 1.2× 17 753
Aaron Kunzer United States 8 302 0.8× 195 1.0× 74 1.0× 18 0.3× 65 1.8× 11 472
Deborah S. Mortensen United States 12 301 0.8× 452 2.3× 80 1.0× 35 0.5× 60 1.6× 28 785
Herwig Pongratz Germany 11 337 0.9× 350 1.8× 134 1.7× 52 0.8× 21 0.6× 18 611
Xin Zhai China 16 369 1.0× 363 1.8× 153 2.0× 20 0.3× 41 1.1× 66 695
Sidney Pitt United States 14 215 0.6× 314 1.6× 70 0.9× 27 0.4× 83 2.2× 16 497
Weifang Tang China 19 351 0.9× 805 4.0× 78 1.0× 45 0.7× 57 1.5× 47 1.1k

Countries citing papers authored by Maryanna E. Lanning

Since Specialization
Citations

This map shows the geographic impact of Maryanna E. Lanning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryanna E. Lanning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryanna E. Lanning more than expected).

Fields of papers citing papers by Maryanna E. Lanning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryanna E. Lanning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryanna E. Lanning. The network helps show where Maryanna E. Lanning may publish in the future.

Co-authorship network of co-authors of Maryanna E. Lanning

This figure shows the co-authorship network connecting the top 25 collaborators of Maryanna E. Lanning. A scholar is included among the top collaborators of Maryanna E. Lanning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryanna E. Lanning. Maryanna E. Lanning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lanning, Maryanna E., et al.. (2020). Rationally Designed Polypharmacology: α‐Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl‐1 and HDM2. ChemMedChem. 15(18). 1691–1698. 12 indexed citations
2.
Lanning, Maryanna E., Wenbo Yu, Jeremy L. Yap, et al.. (2016). Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein. European Journal of Medicinal Chemistry. 113. 273–292. 43 indexed citations
3.
Yap, Jeremy L., Lijia Chen, Maryanna E. Lanning, & Steven Fletcher. (2016). Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules. Journal of Medicinal Chemistry. 60(3). 821–838. 85 indexed citations
5.
Lanning, Maryanna E., Paul T. Wilder, Michael C. Cavalier, et al.. (2015). Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold. Organic & Biomolecular Chemistry. 13(32). 8642–8646. 16 indexed citations
6.
Chen, Lijia, Jeremy L. Yap, Makoto Yoshioka, et al.. (2015). BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536. ACS Medicinal Chemistry Letters. 6(7). 764–769. 73 indexed citations
7.
Jung, Kwan‐Young, Huabo Wang, Peter Teriete, et al.. (2015). Perturbation of the c-Myc–Max Protein–Protein Interaction via Synthetic α-Helix Mimetics. Journal of Medicinal Chemistry. 58(7). 3002–3024. 72 indexed citations
8.
Lanning, Maryanna E. & Steven Fletcher. (2015). Multi-Facial, Non-Peptidic α-Helix Mimetics. Biology. 4(3). 540–555. 12 indexed citations
10.
Whiting, E. E., et al.. (2014). Chromatography-Free Entry to Substituted Salicylonitriles: Mitsunobu-Triggered Domino Reactions of Salicylaldoximes. The Journal of Organic Chemistry. 80(2). 1229–1234. 26 indexed citations
11.
Chen, Lijia, Maryanna E. Lanning, & Steven Fletcher. (2014). Small-Molecule Inhibitors of the Mcl-1 Oncoprotein. 4 indexed citations
12.
Jung, Kwan‐Young, Ramin Samadani, Jay Chauhan, et al.. (2013). Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling. Organic & Biomolecular Chemistry. 11(22). 3706–3706. 28 indexed citations
13.
Lanning, Maryanna E. & Steven Fletcher. (2013). Recapitulating the α-Helix: Nonpeptidic, Low-Molecular-Weight Ligands for the Modulation of Helix-Mediated Protein–Protein Interactions. Future Medicinal Chemistry. 5(18). 2157–2174. 14 indexed citations
14.
Lanning, Maryanna E. & Steven Fletcher. (2013). Azodicarbonyl dimorpholide (ADDM): an effective, versatile, and water-soluble Mitsunobu reagent. Tetrahedron Letters. 54(35). 4624–4628. 18 indexed citations
15.
Jung, Kwan‐Young, Kenno Vanommeslaeghe, Maryanna E. Lanning, et al.. (2013). Amphipathic α-Helix Mimetics Based on a 1,2-Diphenylacetylene Scaffold. Organic Letters. 15(13). 3234–3237. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026